Executive interview - InMed’s cannabinol (CBN) formulation for glaucoma
- 68
In this video, InMed CEO Eric A. Adams speaks about the company's ocular disease program. INM-088 is a cannabinol (CBN) formulation showing potential to ...
Edison
Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations, ESG and strategic consulting. All interviews have been prepared and issued by Edison for publication globally.
View our full disclaimer - http://www.edisoninvestmentresearch.com/disclaimer/client-email-disclaimer
Edison is authorised and regulated by the Financial Conduct Authority (www.fsa.gov.uk/register/firmBasicDetails.do?sid=181584
Lastest news
- KuCoin Research Report Reveals: $1 Billion in Financing and Rising Stablecoin Issuance Amid Market Fluctuations
- Design Firm MARGARITA BRAVA Releases Interview
- Nauticus Robotics Announces Results for the First Quarter of 2024
- Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update
- KuCoin Research Report Reveals: $1 Billion in Financing and Rising Stablecoin Issuance Amid Market Fluctuations
- STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Announces An Investigation of Reneo Pharmaceuticals, Inc. - RPHM